AI-Powered Diagnosis Assistant Software for Brain Diseases

Neurophet AQUA is capable of identifying brain atrophy and WMH from the brain MR images, and thereby aiding in the diagnosis and prognosis assessment of various types of brain disorders.

Request Demo

AI-Powered brain MRI quantification analysis software

MFDS (Korea) certified US-FDA 510(k) cleared CE MDD marked MHLW (Japan) approved HSA (Singapore) approved

Provides clinicians objective evidence to facilitate clinical decision-making for accurate diagnosis and appropriate medical treatment.

Quantifies the brain volume and WMH*, imperceptible with naked eyes.

*WMH: White Matter Hyperintensity

Features

Accurate and quick analysis

Utilizing insights from over 10,000 MR scans, the AI engine utilizes rapid and precise analyses for brain atrophy and WMH.

The analysis result reports enhance communication among medical staff, patients, and caregivers and contribute to effective patient management.

Tracks evolution of brain atrophy

Provides comprehensive reports and charts depicting changes of brain atrophy and white matter changes.

Reports and charts show the changes in brain atrophy and WMH. They offer an objective assessment of brain atrophy evolution based on MRI scans and aid in predicting disease progression.

Automated WMH analysis

Predicts the severity of WMH with the provided Fazekas scale.

Offers trend analysis to monitor changes of WMH over time.

Consistency and reliability for various types of MR scanners

Provides consistent analysis results from the majority of MRI scanners commonly used in medical institutions, both domestically and internationally.

The analysis failure rate is exceptionally low, and the results are reliable due to automatic adjustment for images factors like shaking or undesired motion occurred during scan.